# Medpace (MEDP) Stock Price, News & Catalysts
Canonical URL: https://biopharmsignal.com/company/MEDP
## Company Profile
- Ticker: MEDP
- Exchange: NASDAQ
- Sector: Biopharma
- Location: United States
## Stock Data
- Close: 596.98 USD
- Market cap: 12725911821.51 USD
- Last updated: 2026-08-12
## Business Overview
### Full-Service Clinical Research
Medpace is a global contract research organization providing Phase 1 through Phase 4 clinical-development services to biotechnology, pharmaceutical and medical-device companies.
### Therapeutic and Scientific Expertise
The company uses physician leadership and therapeutic-area specialists to support protocol design, regulatory planning, trial execution and data interpretation. This scientifically driven model is particularly relevant for emerging biotechnology sponsors with limited internal development infrastructure.
### Integrated Trial Operations
Medpace offers project management, clinical monitoring, data management, biostatistics, medical writing, safety and laboratory services through an integrated operating model. Its global network allows sponsors to run multinational studies with a single primary CRO.
## Why The Stock Is Moving

As of Aug 12, 2026, MEDP closed down 1.41% at $596.98. No new same-company headline was identified in the current news window.

## Future Catalysts

- Medpace’s watchlist is backlog conversion, study-start momentum, and how biotech funding trends affect CRO demand. That readout matters because it decides whether the asset is ready for a larger and more expensive development step. If the data come in cleanly, the market tends to give the broader platform behind the program more credit.

## Recent News
- 2026-07-22 20:15 EST — [Medpace Holdings, Inc. Reports Second Quarter 2026 Results](https://biopharmsignal.com/news/MEDP/medpace-holdings-inc-reports-second-quarter-2026-results-b91c0014) — Source: Medpace
- 2026-06-16 20:23 EST — [Medpace Holdings, Inc. to Report Second Quarter 2026 Financial Results on July 22, 2026](https://biopharmsignal.com/news/MEDP/medpace-holdings-inc-to-report-second-quarter-2026-financial-results-on-july-22--c41eebc2) — Source: Medpace
- 2026-04-22 20:15 EST — [Medpace Holdings, Inc. Reports First Quarter 2026 Results](https://biopharmsignal.com/news/MEDP/medpace-holdings-inc-reports-first-quarter-2026-results) — Source: Medpace
- 2026-03-24 20:05 EST — [Medpace Holdings, Inc. to Report First Quarter 2026 Financial Results on April 22, 2026](https://biopharmsignal.com/news/MEDP/medpace-holdings-inc-to-report-first-quarter-2026-financial-results-on-april-22-2026) — Source: Medpace
- 2026-02-09 21:15 EST — [Medpace Holdings, Inc. Reports Fourth Quarter and Full Year 2025 Results](https://biopharmsignal.com/news/MEDP/medpace-holdings-inc-reports-fourth-quarter-and-full-year-2025-results) — Source: Medpace